Total number of Covid-19 clinical trials continues to rise as cases and deaths rise

Big Pharma is forging an increased number of partnerships with artificial intelligence vendors for drug discovery services

Synairgen concludes recruitment in Covid-19 inhaled drug study

UK-based company Synairgen has completed the recruitment of 120 subjects in its Phase II trial...

Could Moderna and BioNTech’s Covid-19 vaccines pave the way for mRNA-based cancer vaccines?

ASCO-GI 2021: Agios will file for a new Tibsovo label in 2L cholangiocarcinoma despite an OS advantage setback

Clinical trials disrupted by slow recruitment still growing

Genkyotex’s setanaxib shows favourable safety profile in Phase I trial

French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its...

Debiopharm begins Phase II trial of alisporivir against Covid-19 in France

Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase...

Grifols to initiate new Covid-19 drug trial in Spain

Grifols is set to initiate a clinical trial in Spain to analyse a new Covid-19...

REMD-477 topline results highlight the benefits of adjunct therapies in type 1 diabetes